Data-driven longevity startup
Location: Singapore
Employees: 11-50
Total raised: $25.26M
Founded date: 2015
Investors 3
| Date | Name | Website |
| 18.05.2024 | Melnichek ... | melnichek.... |
| 15.07.2021 | Plug and P... | plugandpla... |
| - | Bulba Vent... | bulba.com/ |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 19.06.2026 | - | $17M | - |
| 20.10.2023 | Series A | $6M | - |
| 04.08.2020 | Series A | $2.26M | - |
Mentions in press and media 15
| Date | Title | Description |
| 19.06.2026 | Gero Raises $17 Million To Slow Aging | Gero announced it has raised $17 million in new financing, bringing its total equity funding to $34 million. The company is developing medicines designed to slow aging and treat age-related diseases by combining longitudinal human data, AI,... |
| 17.06.2026 | HighGround Raises $6.5M in Seed Funding | HighGround, a Washington, DC-based provider of a data and intelligence layer service, raised $6.5M in Seed funding. The round was led by Next Frontier Capital, with participation from Tandem Ventures, Fulcrum Capital, and Context Ventures. ... |
| 20.10.2023 | Gero Raises $6M for Physics-Powered GenAI Biotech | What You Should Know: Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to continue internal drug development programs, grow its scientific t... |
| 19.10.2023 | Singapore-based Gero raises USD 6 million in Series A extension | Singapore-based physics-powered GenAI biotechnology company focused on ageing and chronic diseases, Gero, raised USD 6 million in Series A extension. The round took place on October 18, 2023. Cyprus-based VC firm dedicated to improving the ... |
| 18.10.2023 | Gero Raises $6M in Series A Extension | Gero, a Palo Alto, CA-based biotechnology company focused on aging and chronic diseases, closed $6M in a Series A extension round. The round was led by Melnichek Investments, with participation from VitaDAO and Leonid Lozner. The company in... |
| 21.12.2022 | Reversing Time: Q&A with Peter Fedichev, founder and CEO of Gero, and Alex Kadet, chief business officer | Founded in 2015, Gero is a biotech company that leverages AI to facilitate the discovery of drugs that can extend one’s lifespan. KrASIA chatted with Peter Fedichev, co-founder and CEO of Gero, and the company’s chief business officer, Alex... |
| 07.05.2021 | Longevity startup Gero AI has a mobile API for quantifying health changes | Sensor data from smartphones and wearables can meaningfully predict an individual’s ‘biological age’ and resilience to stress, according to Gero AI. The ‘longevity’ startup — which condenses its mission to the pithy goal of “hacking complex... |
| 05.08.2020 | Bulba Ventures инвестировал в стартап Gero. Мельничек вошёл в совет директоров | Отдел новостей 5 августа 2020, 09:53 Bulba Ventures инвестировал в стартап Gero. Мельничек вошёл в совет директоров Российско-сингапурский биотех-стартап Gero привлёк 2,2 миллиона долларов инвестиций, сообщает vc.ru со ссылкой на представит... |
| 05.08.2020 | Biotech startup Gero grabs €1.9M to hack ageing and COVID-19 | Based out of Singapore, Gero develops new drugs for ageing and other complicated disorders using its proprietary developed artificial intelligence (AI) platform. Recently, the company has secured $2.2 million (€1.9 million) in Series A fund... |
| 04.08.2020 | Gero Raises $2.2M in Series A Funding | Gero, a Singapore-based company that develops new drugs for ageing and other complicated disorders using its proprietary developed artificial intelligence (AI) platform, secured $2.2m in Series A funding. The round, which brought total capi... |
Show more